Warby Parker (WRBY) Total Current Liabilities (2020 - 2026)
Warby Parker's (WRBY) quarterly Total Current Liabilities came in at $153.3 million in Q1 2026, up 25.01% YoY from $122.6 million in Q1 2025, and up 2.1% on a QoQ basis from $150.1 million in Q4 2025.
Warby Parker (WRBY) Total Current Liabilities (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Total Current Liabilities data on file, last reported at $153.3 million in Q1 2026.
- Quarterly Total Current Liabilities rose 25.01% year-over-year to $153.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $153.3 million (up 25.01% YoY) and the FY2025 annual result came in at $150.1 million, up 15.17% from the prior year.
- Total Current Liabilities rose to $153.3 million in Q1 2026, from $150.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $153.3 million in Q1 2026 to a low of $110.4 million in Q2 2023.
- A 5-year average of $126.7 million and a median of $127.1 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities fell 17.02% — and 2026, when it advanced 25.01%.
- Tracing WRBY's Total Current Liabilities over 5 years: stood at $129.6 million in 2022, then declined by 1.9% to $127.1 million in 2023, then grew by 2.57% to $130.4 million in 2024, then climbed by 15.17% to $150.1 million in 2025, then rose by 2.1% to $153.3 million in 2026.
- The last three Total Current Liabilities figures came in at $153.3 million (Q1 2026), $150.1 million (Q4 2025), and $132.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn | 163.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 163.48 Mn |
| Mar 31, 2026 | 153.28 Mn |
| Dec 31, 2025 | 150.13 Mn |
| Sep 30, 2025 | 132.07 Mn |
| Jun 30, 2025 | 135.53 Mn |
| Mar 31, 2025 | 122.61 Mn |
| Dec 31, 2024 | 130.35 Mn |
| Sep 30, 2024 | 130.12 Mn |
| Jun 30, 2024 | 121.03 Mn |
| Mar 31, 2024 | 118.54 Mn |
| Dec 31, 2023 | 127.09 Mn |
| Sep 30, 2023 | 121.81 Mn |
| Jun 30, 2023 | 110.43 Mn |
| Mar 31, 2023 | 111.04 Mn |
| Dec 31, 2022 | 129.56 Mn |
| Sep 30, 2022 | 111.48 Mn |
| Jun 30, 2022 | 119.86 Mn |
| Mar 31, 2022 | 128.74 Mn |
| Dec 31, 2021 | 118.10 Mn |
| Sep 30, 2021 | 134.36 Mn |